Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Raboud

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
HIV Medicine|September 2, 2014
Predictors of unstructured antiretroviral treatment interruption and resumption among HIV-positive individuals in CanadaH Samji, T E Taha, D Moore, et al.
Antiviral Research|January 2, 2007
Assay of HIV gp41 amino acid sequence to identify baseline variation and mutation development in patients with virologic failure on enfuvirtideM R Loutfy, J M Raboud, J S G Montaner, et al.
HIV Medicine|September 1, 2007
A large prospective study assessing injection site reactions, quality of life and preference in patients using the Biojector vs standard needles for enfuvirtide administrationM R Loutfy, M Harris, J M Raboud, et al.
HIV Medicine|July 8, 2016
Quality of initial HIV care in Canada: extension of a composite programmatic assessment tool for HIV therapyS Kesselring, A Cescon, G Colley, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
HIV Medicine|September 2, 2014
Predictors of unstructured antiretroviral treatment interruption and resumption among HIV-positive individuals in CanadaH Samji, T E Taha, D Moore, et al.
Antiviral Research|January 2, 2007
Assay of HIV gp41 amino acid sequence to identify baseline variation and mutation development in patients with virologic failure on enfuvirtideM R Loutfy, J M Raboud, J S G Montaner, et al.
HIV Medicine|September 1, 2007
A large prospective study assessing injection site reactions, quality of life and preference in patients using the Biojector vs standard needles for enfuvirtide administrationM R Loutfy, M Harris, J M Raboud, et al.
HIV Medicine|July 8, 2016
Quality of initial HIV care in Canada: extension of a composite programmatic assessment tool for HIV therapyS Kesselring, A Cescon, G Colley, et al.
Pageof 4